276 related articles for article (PubMed ID: 30764849)
1. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.
Pérez-Fernández A; López-Ruano G; Prieto-Bermejo R; Ijurko C; Díez-Campelo M; Sánchez-Guijo F; Hernández-Hernández Á
J Exp Clin Cancer Res; 2019 Feb; 38(1):80. PubMed ID: 30764849
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.
Kuo E; Park DK; Tzvetanova ID; Leiton CV; Cho BS; Colognato H
J Neurochem; 2010 Apr; 113(1):200-12. PubMed ID: 20132481
[TBL] [Abstract][Full Text] [Related]
3. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
4. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation.
Gobbi G; Mirandola P; Carubbi C; Micheloni C; Malinverno C; Lunghi P; Bonati A; Vitale M
Blood; 2009 Mar; 113(13):3080-7. PubMed ID: 18988868
[TBL] [Abstract][Full Text] [Related]
6. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
7. Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
Taylor J; Bulek A; Gannon I; Robson M; Kokalaki E; Grothier T; McKenzie C; El-Kholy M; Stavrou M; Traynor-White C; Lim WC; Panagiotou P; Srivastava S; Baldan V; Sillibourne J; Ferrari M; Pule M; Thomas S
Front Immunol; 2023; 14():1119350. PubMed ID: 37334382
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse.
Weinberg JB; Misukonis MA
Cancer Res; 1984 Dec; 44(12 Pt 1):5594-8. PubMed ID: 6594193
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
[TBL] [Abstract][Full Text] [Related]
11. Ethyl acetate extract of Caesalpinia sappan L. inhibited acute myeloid leukemia via ROS-mediated apoptosis and differentiation.
Ma HY; Wang CQ; He H; Yu ZY; Tong Y; Liu G; Yang YQ; Li L; Pang L; Qi HY
Phytomedicine; 2020 Mar; 68():153142. PubMed ID: 32045840
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
[TBL] [Abstract][Full Text] [Related]
13. Angiocidin induces differentiation of acute myeloid leukemia cells.
Tuszynski GP; Rothman VL
Exp Mol Pathol; 2013 Dec; 95(3):249-54. PubMed ID: 24036285
[TBL] [Abstract][Full Text] [Related]
14. ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2/Rho/ROCK1 pathway.
Li L; Xu X; Du Y; Zhang M; Feng Y; Qian X; Li S; Du T; Peng X; Chen F
Toxicol Appl Pharmacol; 2020 Jul; 399():115053. PubMed ID: 32417439
[TBL] [Abstract][Full Text] [Related]
15. Themis-associated phosphatase activity controls signaling in T cell development.
Mehta M; Brzostek J; Chen EW; Tung DWH; Chen S; Sankaran S; Yap J; Rybakin V; Gascoigne NRJ
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11331-E11340. PubMed ID: 30413615
[TBL] [Abstract][Full Text] [Related]
16. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.
Bone H; Dechert U; Jirik F; Schrader JW; Welham MJ
J Biol Chem; 1997 May; 272(22):14470-6. PubMed ID: 9162089
[TBL] [Abstract][Full Text] [Related]
17. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia.
Yehudai D; Liyanage SU; Hurren R; Rizoska B; Albertella M; Gronda M; Jeyaraju DV; Wang X; Barghout SH; MacLean N; Siriwardena TP; Jitkova Y; Targett-Adams P; Schimmer AD
Haematologica; 2019 May; 104(5):963-972. PubMed ID: 30573504
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
19. SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells.
Reich D; Kresinsky A; Müller JP; Bauer R; Kallenbach J; Schnoeder TM; Heidel FH; Fässler R; Mann M; Böhmer FD; Jayavelu AK
Leukemia; 2020 May; 34(5):1444-1449. PubMed ID: 31836852
[No Abstract] [Full Text] [Related]
20. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation.
Koeffler HP; Bar-Eli M; Territo MC
Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]